Ophthalmology News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–8 of 8 articles
Opus Genetics' OPGx-LCA5 Gene Therapy Accepted Into FDA's Rare Disease Evidence Program
Everads Therapy Publishes First-in-Human Clinical Data for Suprachoroidal Injector in Ophthalmology Science
Spinogenix Tazbentetol Shows Neuroprotective Effects in Glaucoma and Diabetic Retinopathy Preclinical Studies at ARVO 2026
Oculis to Present DME Research and Pipeline Updates at ARVO 2026 Annual Meeting
Outlook Therapeutics Completes FDA Dispute Resolution Meeting for LYTENAVA Bevacizumab Biosimilar
LENZ Therapeutics Submits VIZZ Presbyopia Treatment for UK Approval Following EU Validation
Glaukos Receives Permanent J-Code J2789 for Epioxa™ Ophthalmic Treatment, Effective July 2026
FDA Approves LumaGen Gene Therapy for Inherited Retinal Disease